Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Neural Regulation01:37

Neural Regulation

43.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.9K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dystrophic changes of nigrostriatal axons harboring a Synj1 Parkinson mutation suggest catastrophic failure of endocytic mechanisms.

bioRxiv : the preprint server for biology·2026
Same author

Microglial sTREM2 limits dyskinesia and acts on TrkB to support circuit plasticity.

bioRxiv : the preprint server for biology·2026
Same author

Cell- and state-specific plasticity of striatal glutamatergic synapses is critical to the expression of levodopa-induced dyskinesia.

Neuron·2026
Same author

Activity-Dependent Regulation of Basal Forebrain Cholinergic Neurons by Striatal Spiny Projection Neurons.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2026
Same author

N-acetyl-l-leucine lowers α-synuclein levels and improves synaptic function in Parkinson's disease models.

The Journal of clinical investigation·2026
Same author

Mapping cellular vulnerability in Parkinson's disease using retro-AAVs and preformed α-synuclein fibrils.

Translational neurodegeneration·2026

Related Experiment Video

Updated: Mar 8, 2026

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
14:45

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

6.7K

Selective neuronal vulnerability in Parkinson disease.

D James Surmeier1, José A Obeso2,3, Glenda M Halliday4,5

  • 1Department of Physiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA.

Nature Reviews. Neuroscience
|January 21, 2017
PubMed
Summary

Lewy pathology (LP) in Parkinson disease may not spread through the brain as previously thought. Cell-autonomous mechanisms appear to drive both alpha-synuclein pathology and neuronal death in clinical Parkinson disease.

More Related Videos

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

8.0K
Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

11.4K

Related Experiment Videos

Last Updated: Mar 8, 2026

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
14:45

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

6.7K
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

8.0K
Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

11.4K

Area of Science:

  • Neuroscience
  • Neuropathology
  • Parkinson Disease Research

Background:

  • Clinical Parkinson disease (cPD) is characterized by intracellular alpha-synuclein (α-syn)-rich protein aggregates known as Lewy pathology (LP) and neuronal death.
  • The prevailing hypothesis suggests LP emerges early and propagates through connected brain networks, causing dysfunction and death.
  • However, human brain analyses and connectome studies challenge this simple spreading model, indicating LP patterns in cPD are inconsistent with it.

Purpose of the Study:

  • To review the evidence supporting and refuting the model of spreading Lewy pathology in cPD.
  • To explore alternative explanations for the observed patterns of LP and neuronal death in cPD.
  • To examine the role of cell-autonomous factors in α-syn pathology and neuronal death.

Main Methods:

  • Review of post-mortem human brain analyses.
  • Analysis of connectome-mapping studies in cPD.
  • Synthesis of evidence regarding LP propagation and cell-autonomous mechanisms.

Main Results:

  • The observed pattern of LP in cPD does not align with a simple network-spreading model.
  • Evidence suggests that if LP propagates, it is modulated by cell- or region-autonomous mechanisms.
  • The correlation between LP and neuronal death in cPD is weak.

Conclusions:

  • The simple model of LP spreading through brain networks in cPD requires re-evaluation.
  • Cell-autonomous factors likely play a significant role in governing both α-syn pathology and neuronal death.
  • Further research is needed to elucidate the complex interplay between LP, neuronal death, and cell-autonomous mechanisms in Parkinson disease pathogenesis.